HLB Pharmaceutical Market Cap

HLB Pharmaceutical has a market cap or net worth of 248.41 billion as of April 28, 2026. Its market cap has decreased by -11.77% in one year.

Market Cap

248.41B

Enterprise Value

246.96B

Revenue

205.58B

Ranking

n/a

PE Ratio

126.36

Stock Price

17,700.00

Market Cap Chart

Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 248.41B, an increase of 194.74%. That is a compound annual growth rate of 11.00%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	248.41B	10.29%
Dec 30, 2025	225.24B	-33.44%
Dec 30, 2024	338.42B	58.45%
Dec 28, 2023	213.58B	43.49%
Dec 29, 2022	148.85B	-21.48%
Dec 30, 2021	189.57B	-21.05%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Boditech Med	244.14B
Hyundai Pharmaceutical	239.14B
Chong Kun Dang Holdings	238.98B
Daewon Pharmaceutical	234.27B
Samjin Pharmaceuticals	232.04B
CMG Pharmaceutical	268.19B
Suheung	218.94B
AptaBio Therapeutics	217.72B

Market Cap Rankings